Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TZP-102 in diabetic gastroparesis
NCT01452815Phase 2Completed
- Sponsor
- Tranzyme Pharma
- Start
- Sep 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 8
01
Overview
A Phase 2 trial of ulimorelin in diabetic gastroparesis, sponsored by Tranzyme Pharma. Started Sep 2011; status: completed.
02
Drugs
ulimorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT01452815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452815.